Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,318 papers from all fields of science
Search
Sign In
Create Free Account
Systemic Lupus Erythematosus Disease Activity Index
Known as:
SLEDAI
A clinical index for the measurement of disease activity in systemic lupus erythematosus. The index utilizes 24 weighted variables that measure…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Research or Clinical Assessment Tool
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids.
Noha A. Azab
,
I. Bassyouni
,
Y. Emad
,
G. A. A. El-Wahab
,
Gehan Hamdy
,
M. A. Mashahit
Clinical Immunology
2008
Corpus ID: 39050570
Highly Cited
2008
Highly Cited
2008
Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus
C.-S. Lee
,
C-Y Hu
,
+4 authors
P. Hsu
Clinical and Experimental Immunology
2008
Corpus ID: 41182594
Decoy receptor 3 (DcR3/TR6) is a decoy receptor for the Fas ligand (FasL) and can inhibit FasL‐induced apoptosis. It has been…
Expand
Highly Cited
2007
Highly Cited
2007
Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
S. Nakano
,
S. Morimoto
,
+4 authors
Y. Takasaki
Rheumatology
2007
Corpus ID: 6103244
OBJECTIVES Toll-like receptor 9 (TLR9) is a pattern-associated receptor functioning in innate immunity that may be involved in…
Expand
Highly Cited
2002
Highly Cited
2002
Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage.
Y. Molad
,
E. Miroshnik
,
Jaqueline Sulkes
,
Silvio Pitlik
,
A. Weinberger
,
Y. Monselise
Clinical and Experimental Rheumatology
2002
Corpus ID: 22516586
OBJECTIVE To determine the urinary levels of soluble vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion…
Expand
2001
2001
Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients.
L. Liou
Clinical and Experimental Rheumatology
2001
Corpus ID: 37193018
OBJECTIVE To examine the correlation between C-reactive protein (CRP) and CRP-inducing cytokines (IL-1 beta, IL-6, TNF-alpha) and…
Expand
Highly Cited
2000
Highly Cited
2000
Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity.
M. Abu-Shakra
,
S. Zalmanson
,
Lily Neumann
,
D. Flusser
,
Shaul Sukenik
,
D. Buskila
Journal of Rheumatology
2000
Corpus ID: 731248
OBJECTIVE To determine whether vaccination of patients with systemic lupus erythematosus (SLE) with influenza virus vaccine is…
Expand
Highly Cited
1999
Highly Cited
1999
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation.
A. Swaak
,
H. V. D. Brink
,
+23 authors
J. Smolen
Rheumatology
1999
Corpus ID: 8988256
OBJECTIVE Most information available about the disease course of patients with systemic lupus erythematosus (SLE) is restricted…
Expand
Highly Cited
1998
Highly Cited
1998
Effect of 1 year cyclosporine a treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study
C. Dostal
,
V. Tesar
,
+5 authors
D. Tegzová
Lupus
1998
Corpus ID: 7538837
Our objective was to determine the effect of 1 year low-dose cyclosporine A (CSA) treatment on disease activity and renal…
Expand
1998
1998
A study of the association of HLA DR, DQ, and complement C4 alleles with systemic lupus erythematosus in Iceland
K. Steinsson
,
S. Jónsdóttir
,
+4 authors
A. Arnason
Annals of the Rheumatic Diseases
1998
Corpus ID: 12087792
OBJECTIVE To perform an exploratory analysis of the relative contribution of single MHC genes to the pathogenesis of systemic…
Expand
Highly Cited
1995
Highly Cited
1995
The value of complement activation products in the assessment of systemic lupus erythematosus flares.
J. Porcel
,
J. Ordi
,
+6 authors
D. Vergani
Clinical Immunology and Immunopathology
1995
Corpus ID: 35486633
Complement activation products (CAP) have been reported as sensitive markers of disease activity in systemic lupus erythematosus…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE